Johnson & Johnson Innovation Opens Partnering Office in Stevenage Bioscience Catalyst
LONDON (June 20 2013) Johnson & Johnson Innovation today announced the establishment of a partnering office at Stevenage Bioscience Catalyst to support emerging entrepreneurs and biotech companies in the region. As part of a broader strategy to interact with the UK Life Sciences ecosystem, science and business experts from the London Innovation Centre of Johnson & Johnson Innovation will have a regular presence at Stevenage Bioscience Catalyst to interact with companies in residence who are advancing concepts and technologies with the potential to transform patient healthcare.
This collaboration with Stevenage Bioscience Catalyst reflects Johnson & Johnson Innovation’s commitment to the open innovation and collaboration that is necessary to tackle urgent unmet medical needs.
“Our goal in placing four regional innovation centers in life science hotspots such as London, is to integrate our science and business experts with innovators and entrepreneurs in these communities so that together we can support a strong biotech industry and advance promising healthcare solutions,” noted Dr. Kurt Hertogs, Incubator Strategy Leader for Johnson & Johnson Innovation in the London Innovation Centre. “Collaboration within the unique incubator environment of Stevenage Bioscience Catalyst, which was created to provide small organizations access to the resources of larger pharmaceutical companies, is one of the steps we can take to help advance these goals.”
About J&J Innovation
The London innovation centre is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Limited. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. More information can be found here: www.jnjinnovation.com.